Differential development of neuronal physiological responsiveness in two human neural stem cell lines by Donato, Roberta et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
BMC Neuroscience
Open Access Research article
Differential development of neuronal physiological responsiveness 
in two human neural stem cell lines
Roberta Donato†1, Erik A Miljan†2, Susan J Hines2, Sihem Aouabdi2, 
Kenneth Pollock2, Sara Patel2, Frances A Edwards1 and John D Sinden*2
Address: 1Department of Physiology, University College London, Gower Street, London, WC1E 6BT, UK and 2ReNeuron Limited, 10 Nugent Road, 
Surrey Research Park, Guildford, Surrey, GU2 7AF, UK
Email: Roberta Donato - r.donato@ucl.ac.uk; Erik A Miljan - erik-miljan@reneuron.com; Susan J Hines - susan-hines@reneuron.com; 
Sihem Aouabdi - sihem-aouabdi@reneuron.com; Kenneth Pollock - kenny-pollock@reneuron.com; Sara Patel - sara-patel@reneuron.com; 
Frances A Edwards - f.a.edwards@ucl.ac.uk; John D Sinden* - john-sinden@reneuron.com
* Corresponding author    †Equal contributors
Abstract
Background: Neural stem cells (NSCs) are powerful research tools for the design and discovery
of new approaches to neurodegenerative disease. Overexpression of the myc family transcription
factors in human primary cells from developing cortex and mesencephalon has produced two stable
multipotential NSC lines (ReNcell VM and CX) that can be continuously expanded in monolayer
culture.
Results: In the undifferentiated state, both ReNcell VM and CX are nestin positive and have resting
membrane potentials of around -60 mV but do not display any voltage-activated conductances. As
initially hypothesized, using standard methods (stdD) for differentiation, both cell lines can form
neurons, astrocytes and oligodendrocytes according to immunohistological characteristics.
However it became clear that this was not true for electrophysiological features which designate
neurons, such as the firing of action potentials. We have thus developed a new differentiation
protocol, designated 'pre-aggregation differentiation' (preD) which appears to favor development
of electrophysiologically functional neurons and to lead to an increase in dopaminergic neurons in
the ReNcell VM line. In contrast, the protocol used had little effect on the differentiation of ReNcell
CX in which dopaminergic differentiation was not observed. Moreover, after a week of
differentiation with the preD protocol, 100% of ReNcell VM featured TTX-sensitive Na+-channels
and fired action potentials, compared to 25% after stdD. Currents via other voltage-gated channels
did not appear to depend on the differentiation protocol. ReNcell CX did not display the same
electrophysiological properties as the VM line, generating voltage-dependant K+ currents but no
Na+ currents or action potentials under either stdD or preD differentiation.
Conclusion:  These data demonstrate that overexpression of myc in NSCs can be used to
generate electrophysiologically active neurons in culture. Development of a functional neuronal
phenotype may be dependent on parameters of isolation and differentiation of the cell lines,
indicating that not all human NSCs are functionally equivalent.
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Background
Over the last decade, neural stem cells have become a
major focus of interest in the development of therapies for
a range of central nervous system disorders. Parkinson's
disease has been perhaps the most directly pursued due to
the focal and relatively well understood nature of the
degeneration (for review see [1,2]). However, other pres-
ently incurable conditions, such as Huntington's and
Alzheimer's diseases, also represent potential targets for
such therapies (for review see [3]).
Previous research has used a wide range of neural stem
cells (NSCs) from adult, fetal and embryonic origin, but
mostly from rodent sources. In the case of human cells,
the capacity to grow these cells while maintaining a stable
phenotype across passages is limited. Thus, the develop-
ment of immortal cell lines to provide suitable cells in
large enough numbers as and when required is an impor-
tant aim. The cells of choice for this purpose are human
neural stem cells (hNSCs), which have two defining prop-
erties: self-renewal and multipotentiality. This capacity of
NSCs to divide in culture and their ability to differentiate
into multiple neuronal cell types makes them attractive as
both a therapy for treating neurological disease and as
powerful tools in the research laboratory.
Whilst a variety of rodent stem cell lines have been differ-
entiated and transplanted into various animal models (for
review see [4]) only a few earlier studies have used human
embryonic or fetal stem cells and demonstrate truly func-
tional differentiation into neurons. Functional testing is
essential as it has been shown that immunological charac-
terisation of neuronal markers does not necessarily reflect
functionality [5]. Perhaps the most thorough study is that
of Piper et al. who demonstrated differentiation of fetal-
derived NSCs into neurons which they showed to have a
variety of ligand and voltage-gated channels [6]. However,
they were not fully functional as the density of voltage-
dependent sodium channels was not sufficient to allow
action potential generation. Another study, using cultures
of human fetal brain tissue, found similar results [7]. In
serum free conditions embryonic stem cells were differen-
tiated into tyrosine hydroxylase (TH) containing cells
which were demonstrated to release dopamine and have
some of the electrical properties of neurons but again no
action potentials were recorded. These cells were shown to
survive in vivo in 6-hydroxydopamine lesioned rat brains
[8]. Glutamatergic and GABAergic neurons have also been
differentiated from human fetal forebrain under defined
conditions [9]. These researchers studies clearly demon-
strated ligand-gated responses, although the ability to fire
action potentials was not discussed. In contrast, Perrier et
al. directed embryonic stem cells to become dopaminergic
neurons capable of firing action potentials using feeder
layer co-cultures [10]. Another successful method was
developed by Wu et al. in which pretreatment of fetal
hNSCs with a mixture of fibroblast growth factor, heparin
and laminin, followed by several days of differentiation,
produced cholinergic neurons which reliably fired action
potentials [11].
There have thus been very few reports of fully functional
neurons derived from human embryonic or fetal derived
stem cells. Moreover a further limitation for using many
fetal-derived hNSCs has been their mortality when grown
in culture [12]. For example, the cell viability in the study
of Piper et al. was limited at 5 passages before differentia-
tion [6]. Recently the life spans of human fetal-derived
neural stem cells in culture have been enhanced by
improvements in growth conditions [13]. However,
immortalization using the myc transcription factor has
proven highly effective at extending the normal life span
of human NSCs in vitro and maintaining a stable genotype
and phenotype (for reviews see [14,15]). Long term cell
expansion with associated karyotype stability is a feature
of myc immortalization [16]. Traditionally thought of as
a proto-oncogene, it has been recently reported that myc
may be a 'stemness' gene driving rapid proliferation yet
maintain multipotentiality in stem cells [17].
The aim of this study was thus to develop human neuro-
nal stem cells which can be cultured, long-term, in a pro-
liferative undifferentiated state so that they can be
expanded as needed and then differentiated into appro-
priate neurons. While these cell lines themselves are
purely for research and could not be used in human ther-
apy, this study paves the way for development of thera-
peutic stem cell lines using similar technology. We
hypothesized that, using immortalized stem cell lines,
cells prevented from differentiation by the presence of
growth factors would lack neuronal phenotype [18,19],
both when tested for morphological markers and electro-
physiological criteria. In contrast, after removal of growth
factors, differentiation would occur as expected. Neurons
would be detectable using morphological markers as
shown previously in many preparations, but this would
also be accompanied by electrophysiological maturation
with the development of voltage-gated channels, allowing
generation of action potentials. To this end we used two
immortalized stem cell lines from two anatomically dis-
tinct brain regions: midbrain (VM) and cortex (CX), and
developed a protocol to maximise differentiation of the
midbrain-derived cell line into dopaminergic neurons as
identified by immunocytochemical markers. Both the cell
lines used for this study were immortalized with the myc
oncogene: ReNcell VM with v-myc while ReNcell CX was
immortalized with c-myc. Moreover, ReNcell VM origi-
nated from a bulk-derived culture and ReNcell CX from a
clonal cell line.BMC Neuroscience 2007, 8:36 http://www.biomedcentral.com/1471-2202/8/36
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Results
Phenotype and function of undifferentiated ReNcell VM 
and CX
ReNcell VM and CX were confirmed to carry the v-myc
and c-myc transgene respectively by RT-PCR (Figure 1A).
G-banded karyotype analysis of the cell lines showed a
normal human male diploid (46, XY) karyotype on four
independent occasions. Tested on multiple passages (26
and 36 for ReNcell VM; 3 and 30 for ReNcell CX) a normal
karyotype was consistently observed, supporting the role
of myc in generating karyotypically stable cell lines. Under
routine growth conditions both ReNcell VM and CX dis-
played an immature neural morphology (Figure 1B, C):
small polygonal cells with few processes that developed
into a tight cobble-stone pattern when confluent. For
practical reasons experiments reported here were carried
out on cultures between passage 15 and 30. ReNcell CX
displayed a higher degree of migration within the culture
dish with a more spiny-shaped morphology than ReNcell
VM. Both cell lines showed similar population doubling
times of around 30 h in peak log-phase growth though the
growth of the CX line was more linear (Figure 1D). Both
undifferentiated cell lines expanded as islands of cells and
show a positive signal for the neural stem cell marker nes-
tin [20] as shown by western blotting (Figure 1E). This
was confirmed by immunocytochemistry, with 100% of
cells stained positively for nestin (Figure 1F, G). Both
undifferentiated cell populations showed rare examples
of spontaneously differentiated cells that were βIII-tubu-
lin (neuronal), GFAP (astrocytic) or O1/Gal C (oli-
godendrocyte) positive (representative images of ReNcell
CX shown in Figure 2A, C, E, G).
Whole cell patch clamp techniques were used to investi-
gate the electrophysiological properties of the cells. Cur-
rent-voltage relationships were recorded in
undifferentiated cells at 3–4 days after passage onto cov-
erslips. For ReNcell VM, data were obtained from five cells
from five different coverslips. Resting membrane poten-
tial in these cells was -60 ± 11 mV and input resistance 167
± 52 MΩ (mean ± SE, n = 5). ReNcell CX cells displayed
similar properties with a resting membrane potential of -
61 ± 10 mV and input resistance of 230 ± 70 MΩ, (n = 6,
see Figure 3C). Under current clamp, only an Ohmic
change in membrane potential was seen in either cell line
in response to stepping up current in 50 pA increments
(for ReNcell VM see Figure 4A). Similarly, under voltage
clamp, no voltage-dependent changes in current were
evoked over a range of holding potentials, -60 to +30 mV
in either ReNcell VM or CX (Figure 4B). Indeed, both the
peak and steady state current voltage relationships were
linear throughout the voltage range tested (Figure 4C),
indicating the absence of voltage-activated conductances.
Maturation of ReNcell VM and CX phenotype following 
differentiation
Initially a standard monolayer differentiation (stdD) pro-
tocol in laminin coated wells was used with growth factors
simply being omitted from the medium and differentia-
tion continuing under the same culture conditions as had
been used for growth of the undifferentiated cells (Figure
3A). Mitogen withdrawal is considered to be the simplest
Characterization of growth, morphology and nestin in undif- ferentiated cells in culture Figure 1
Characterization of growth, morphology and nestin 
in undifferentiated cells in culture. Cell lines are con-
firmed to express the myc transgene as shown by RT-PCR 
(A). Images of ReNcell VM (B) and CX (C) as monolayer cul-
tures. D) Growth of cells within a passage showing cells 
plated at ~5000 cells/cm2 achieve confluency within 3 days in 
culture with equivalent growth rates as measured using 
CyQuant fluorescent assay. ReNcell lines are positive for the 
neural stem cell marker nestin by western blot (E) and immu-
nocytochemistry in green on ReNcell VM (F) and CX (G) 
with Hoechst nuclear counter stain in blue. (B, C) and (F, G) 
compare the two cell lines, scale bar: 100 µm.
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method to induce differentiation of neural stem cells [19]
and is therefore termed "standard differentiation" in our
laboratory. Under these conditions morphological and
phenotypic changes in both cell lines were noted follow-
ing initiation of differentiation. Within 4 days both cell
lines acquired clearly defined, rounded cell bodies with
extensive neurite outgrowths (ReNcell CX shown in Figure
2B). Using immunocytochemistry following stdD, cells
from all three neuronal lineages – neurons, astrocytes and
oligodendrocytes – were positively identified (ReNcell CX
shown in Figure 2D, F, H. Similar results were found for
ReNcell VM, results not shown).
Neural stem cells have the ability to grow as neurospheres
[21,22]. We investigated the effect of selecting cells from
neurospheres before plating onto laminin-coated wells
and following the standard procedure. This was achieved
by plating undifferentiated cells onto uncoated plastic to
which the cell adhere weakly and migration does not
occur. After leaving the cells untouched for 5–7 days in
medium plus growth factors, many cells died but a pro-
portion of the cells expanded into neurosphere-like struc-
tures approximately 100–200 µm in diameter. When such
spheres were transferred to laminin-coated dishes and
then kept in an undifferentiated state for a further 3–4
days before removal of growth factors, the cells from the
sphere migrated onto the substrate during the growth
phase and formed a confluent monolayer prior to initia-
tion of differentiation.
Clearly, when growth factors were removed (as for the
standard procedure) both ReNcell CX and VM cell lines
differentiated and showed strong labeling for the neuro-
nal marker βIII-tubulin (Figure 5A, B, Cii, Dii). However,
differences between the two stem cell lines became appar-
ent at this stage of the preD protocol. Cells from the ReN-
cell CX line spread across the dish behaving similarly to
those under the standard protocol described above. In
contrast, the cells from the ReNcell VM tended to bunch
Differentiation protocols used and the passive properties of  different cell types under the different protocols Figure 3
Differentiation protocols used and the passive prop-
erties of different cell types under the different pro-
tocols. Schematic diagrams of stdD (A) and preD (B) 
differentiation protocols. The passive properties of undiffer-
entiated (control) and differentiated (stdD and preD) ReN-
cell VM and CX are compared (C).
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Multipotentiality of ReNcell CX using standard differentiation  assay showing neuronal, astrocytic and oligodendrocyte  progeny upregulated in the differentiation state Figure 2
Multipotentiality of ReNcell CX using standard differ-
entiation assay showing neuronal, astrocytic and oli-
godendrocyte progeny upregulated in the 
differentiation state. A-H) Representative images of con-
trol and differentiated cells showing βIII-tubulin in green (A, 
B); GFAP in red (C, D); O1 (E, F) and Gal C in green (G, H) 
with Hoechst nuclear counterstain in blue. Arrows highlight 
spontaneous differentiated cells in the control-undifferenti-
ated cultures. Scale bar 100 µm for all images. Similar label-
ling was observed in ReNcell VM (data not shown).
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into dense patches. This could be prevented by adding
cAMP and GDNF to the medium during the differentia-
tion phase (compare Figures 5B &5Ci). Subsequently this
enriched medium was used for these studies for both cell
lines. It seems likely that the lack of foci in the enriched
medium may arise from an increase in cell motility,
potentially enhanced by the addition of GDNF [23], but
this was not further studied.
Development of dopaminergic phenotype in ReNcell VM 
neurons but not in ReNcell CX neurons
We were particularly interested in finding conditions in
which these cell lines might differentiate into dopaminer-
gic neurons. However, staining for the dopaminergic
marker TH was not observed in the differentiated ReNcell
CX neurons (data not shown). In contrast, after differenti-
ation, strong TH expression was shown in the ReNcell VM
neurons both by Western blot and immunocytochemical
analysis (colabelling of TH and βIII-tubulin, Figure 5).
Interestingly, the pre-aggregation differentiation (preD,
Differentiation of ReNcell VM into a dopaminergic neural  phenotype Figure 5
Differentiation of ReNcell VM into a dopaminergic 
neural phenotype. A) Using the preD protocol there is a 
significant increase in TH and βIII-tubulin protein expression 
as assayed by western blot (- undifferentiated, + differenti-
ated with α-tubulin as a loading control). B) Following preD 
(without cAMP/GDNF), the cells are gathered in clusters 
which are strongly labelled with βIII-tubulin (green). TH (red) 
positive neurons are also evident but the clustering makes 
colocalization difficult to differentiate (data not shown). Ci, ii, 
iii) ReNcell VM preD in the presence of cAMP/GDNF shows 
a more even distribution of neuronal differentiation positive 
for βIII-tubulin (Ci, green) and TH (Cii, red), with the overlay 
showing co-localization of the two antigens (Ciii). Di, ii, iii). A 
higher resolution image, under the same conditions as C, 
show individual neurons stained with βIII-tubulin (Di, green) 
and TH (Dii, red), with the overlay showing co-localization 
(Diii). Scale bar: 100 µm.
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Current-voltage relationships in undifferentiated ReNcell VM Figure 4
Current-voltage relationships in undifferentiated 
ReNcell VM. A) Example of voltage responses from a rest-
ing potential of ~-80 mV to current steps of increasing ampli-
tude in a cell (50 pA steps from 50 pA to 500 pA, 400 ms 
duration). B) Current responses to voltage steps of 10 mV, 
from the holding potential of -60 mV to +30 mV, in the same 
cell shown in A). C) Average voltage-current relationship for 
the peak (solid squares) and the steady (open squares) cur-
rent in undifferentiated ReNcell VM (n = 4). The lines repre-
sent linear regressions of the two data sets with r2 > 0.99 in 
both cases.
A
B
C pA
mV
-50 -25 0 25 50
1000
2000
peak
steady state
50mV
100ms
100ms
200pABMC Neuroscience 2007, 8:36 http://www.biomedcentral.com/1471-2202/8/36
Page 6 of 11
(page number not for citation purposes)
Figure 3B) protocol (with the addition of cAMP and
GDNF) seemed to enhance the dopaminergic phenotype
of the ReNcell VM line. Although TH staining alone does
not provide conclusive evidence that these are indeed
dopaminergic neurons, it is sufficient for the purpose of
monitoring and optimization of the differentiation proto-
cols.
Electrophysiological characteristics of differentiated 
ReNcells using the preD protocol
In contrast to the undifferentiated cells described above,
differentiated ReNcell VM consistently displayed active
currents. Recordings were made during the second week
after differentiation. When current steps were injected at
this stage, action potentials were elicited in 8/8 cells tested
(Table 1; Figure 6A). An additional 2/2 cells tested after 29
days of differentiation also featured action potentials.
While we did not concentrate on testing these later time
points, this indicates that at least in some cases long-term
survival of the neurons is possible. If tested earlier, at 6
days after differentiation, the occurrence of action poten-
tials was less consistent (9/15 cells) and, unlike at later
stages, may have been dependent on plating density
(Table 1). ReNcell VM action potentials were consistently
blocked in the presence of 0.6 µM tetrodotoxin (TTX). In
voltage clamp experiments the current responses to volt-
age steps activated a fast inward current, which was abol-
ished in the presence of TTX (Figure 6C, D). Figure 6E and
6F show the average and steady state peak inward current
evoked by stepping the command voltage from -60 to +30
mV in 10 mV increments (n = 14). The fast inward current
was activated at voltages positive to -20 mV and reversed
at voltage positive to +20 mV. The fact that the current was
abolished in the presence of 0.6 µM TTX indicated that it
was mediated by the activation of the type of Na2+-chan-
nels which underlies the generation of action potentials.
The average steady-state current-voltage relationship was
also non-linear (Figure 6F) suggesting that other voltage-
gated channels were also activated. Other voltage-gated channels
While we have not studied other channels in detail, it is
clear that some other voltage-gated channels are present.
An important contributing conductance is probably the
potassium conductance, IA. (See Methods section for the
protocol for isolation of IA). Current consistent with IA
was present in all cells tested though we cannot discount
a possible contribution from Ca2+ channels or other chan-
nels differentially activated by the two protocols (data not
shown).
Comparison between preD and stdD protocols
The preD protocol was used for the above experiments
because of the observation that it enhanced the propor-
tion of TH-positive neurons among the differentiated
ReNcell VM neurons. To investigate whether the preD pro-
tocol affected the development of action potentials, we
ReNcell VM current-voltage responses following preD Figure 6
ReNcell VM current-voltage responses following 
preD. A, B) Example of firing elicited by stepping the current 
command in 20 pA steps (400 ms duration) from a resting 
potential of ~-75 mV in ReNcell VM 10 days after differentia-
tion was started in control solution (A) and after adding 0.6 
µM TTX (B). C, D) Same cell as in (A, B) responding with 
inward currents to incremental voltage steps (10 mV, from -
60 mV to + 30 mV, 400 ms duration), before (C) and after 
(D) adding 0.6 µM TTX to the control solution. E) Average 
inward current-voltage relationships in control differentiated 
(solid squares) and after adding 0.6 µM TTX (open squares) 
and F) average steady-state current-voltage relationship for 
control (solid squares) and TTX treated (open squares).
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Table 1: Development of action potentials in preaggregated VM 
ReNcells is independent of plating density
Plating Density Cells with APs/total tested
6 days differentiation
1:1 1/2
1:2 2/7
1:4 6/6
> 8 days differentiation
1:2 3/3
1:4 4/4
1:8 3/3BMC Neuroscience 2007, 8:36 http://www.biomedcentral.com/1471-2202/8/36
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also studied ReNcell VM using the original stdD protocol.
StdD cultures were studied in the same time frame as for
the preD ReNcell VM, 7–14 days after differentiation. In
these conditions, cells displayed a resting membrane
potential of -52 ± 7 mV and an input resistance of 625 ±
130 MΩ (n = 15). However, only in 25% of cases (4/15)
could Na+ conductances be activated by stepping the volt-
age towards positive values. Even for those cells with
inward currents the Na+ currents were on average consid-
erably smaller and more varied than for the preD protocol
(data not shown). Unlike for sodium currents, the ampli-
tude and voltage dependency of IA in differentiated ReN-
cell VM was independent of the protocol used.
Development of voltage-gated currents in ReNcell VM but 
not CX
Having observed that, although not completely depend-
ent on preD, the development of Na+ currents was sub-
stantially enhanced by the preD compared to the stdD, we
then checked both protocols in ReNcell CX. ReNcell CX
cells studied over the second week after preD had a resting
membrane potential of -33 ± 5 mV and an input resistance
of 1033 ± 203 MΩ (n = 15). No action potentials or
inward currents could be generated in any of the cells
tested (0/12) in response to injection of current or voltage
in steps of increasing positive amplitude (from a starting
potential of ~-80 mV, Figure 7A, B). Like ReNcell VM cells,
ReNcell CX displayed a non-linear current-voltage rela-
tionship (Figure 7C, n = 9), suggesting the presence of
voltage-activated conductances.
We have restricted our analysis of other voltage-gated
channels to IA. We find that the presence of IA was inde-
pendent of cell type or protocol being similar to that seen
in ReNcell VM (Figure 7D). The passive properties of ReN-
cell CX are compared to those of ReNcell VM under differ-
ent conditions in Figure 3C. Overall, in contrast to the
ReNcell VM neurons, the use of the preD protocol did not
show any measurable effects on ReNcell CX neurons.
Discussion
We have developed immortalized human fetal neural
stem cell lines from the cortex (CX) and from the ventral
mesencephalon (VM) regions of the brain and tested their
differentiation potential and functional capacity under
different culture conditions. These two brain areas were
chosen as they are of particular interest as research models
of cellular processes occurring during the development of
degenerative diseases such as Huntington's, Alzheimer's
and Parkinson's diseases. Our initial hypothesis that mor-
phological differentiation of the stem cells into neurons
would also be reflected in their electrophysiological char-
acteristics was not supported by the data.
When comparing the two stem cell lines under the same
culture conditions, undifferentiated ReNcell VM and CX
displayed very similar phenotypes. Both cell lines in the
undifferentiated state were indistinguishable in their nes-
tin expression, as well as their electrophysiological prop-
erties. Moreover, on differentiation
immunohistochemical characteristics were also similar in
that both cell lines showed a similar level of neuronal
development as judged from staining for βIII-tubulin
though only the mesencephalic stem cells showed signifi-
cant positive staining for TH, a marker for dopaminergic
neurons. However, despite the immunological evidence
of neuronal development in both cell lines, functional
evidence for neuronal differentiation – the ability to gen-
erate action potentials – was only observed in the ReNcell
VM neurons. ReNcell CX cells cultured under identical
conditions did not develop this physiological phenotype.
This aspect of neuronal function was particularly
enhanced in ReNcell VM by allowing the cells to form
neurospheres before plating and subsequent removal of
growth factors to allow differentiation. Interestingly,
although the capacity to form neurospheres was also evi-
dent in the cortical stem cells, this predifferentiation step
Electrophysiological properties of ReNcell CX Figure 7
Electrophysiological properties of ReNcell CX. A, B) 
Example of ReNcell CX 12 days after differentiation was 
started using the preD protocol, responding to current (A; 
from ~-80 mV) or voltage (B) steps (10 pA or mV incre-
ments, 400 ms). C) Average voltage-current relationship for 
the peak current elicited by stepping the voltage from -60 to 
+ 30 mV in 10 mV increments for the ReNcell CX with the 
preD (solid circles, n = 9) or the stdD (open circles, n = 7) 
protocols. D) Average IA peak current for the ReNcell CX 
differentiated using preD (filled circles, n = 9) or the stdD 
(open circles, n = 7) protocols. Despite the apparent trend 
there is no significant difference between these groups due 
to the large scatter in the data.
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made no apparent difference to the subsequent differenti-
ation of ReNcell CX cells.
It has previously been proposed that the differences seen
between electrophysiology studies of NSCs are due to var-
iations in culture conditions [7]. ReNcell VM and CX were
both maintained long-term in identical culture conditions
and although the same differentiation and recording pro-
tocols were used, the two lines gave different functional
outcomes. This suggests that the two cell lines are either
intrinsically different or neuronal maturation is affected
by differences in derivation of the cell lines. It is possible
that similar outcomes may in the future be achieved by
designing differentiation protocols specific for ReNcell CX
to generate functional neurons. There are, however, signif-
icant differences and this may relate to how the cell lines
were actually derived, either in terms of: 1) the brain area
from which they are derived; 2) the derivation of ReNcell
CX from a clonal cell line versus ReNcell VM from a bulk
derived culture; or 3) the use of v-myc versus c-myc for
immortalization of the lines.
It is unlikely that the area of the brain from which the cells
are derived results in this difference as it is clear that stem
cells must exist in fetal cortical tissue which can differen-
tiate into fully functional neurons [11]. However, whether
the cells are clonal or derived from bulk tissue may be a
factor leading to the variability in the results observed
between the two cell lines. The second difference seems a
more likely source of the final outcomes observed. It is
possible that the myc integration site within the genome
of the clonal ReNcell CX line has disrupted a gene expres-
sion pattern required for functional neural differentiation.
Alternatively, in the case of development of the VM line
from bulk tissue, a variety of neural stem cells with vary-
ing degrees of commitment remain in the culture while
the CX cells derived from a single initial cell would only
represent one subtype of stem cell. Thus, contrary to the
assumption that neural stem cells derived from fetal tissue
are all equally multipotent, this may suggest that within
any tissue, a variety of stem cells exists each with its own
committed limits of differentiation. Each type may be
able to proliferate indefinitely and differentiate into
immunologically identifiable neurons, astrocytes and oli-
godendrocytes. They would thus be defined as neural
stem cells [21,24] but the eventual potential or require-
ments for functional differentiation into specific cell types
may vary within the population. Neurosphere formation
may select for a particular cell subtype which can compete
best under these conditions which can subsequently dif-
ferentiate into fully functional neurons, including
dopaminergic neurons. The CX line, being derived from a
single cell, would not have such variation and thus select-
ing neurospheres would make no difference as the cells
would all be identical. Interestingly, only one previous
study has succeeded in differentiating similarly derived
human fetal stem cells to become functional neurons
which were confirmed to fire action potentials [11].
Rather than being clonal, these cells were derived from
cortical bulk tissue thus further supporting our suggestion
that it is the subsequent preparation of the cells and not
their origin which is important in the differences seen.
We cannot discount the possibility that these outcomes
originate from the third difference listed above – the use
of different proto-oncogenes for immortalization. ReNcell
VM was immortalized using v-myc and ReNcell CX with c-
myc proto-oncogenes. c-Myc is described as the human
homolog of avian v-myc [25]. Although c-myc is larger in
size, they are considered to be homologous because they
contain the same transforming domains [26] with the
same subcellular localization to the nucleus [27]. v-Myc
may be a more potent immortalization agent than c-myc.
This has been attributed to mutations in the v-myc gene
which enhance the transformation ability of myc [28];
however, the presence of v-myc polymorphisms has not
been investigated in ReNcell VM. Moreover, during differ-
entiation of human NSCs, myc transgene expression was
shown to be down-regulated [16]. The presence of v-myc
cannot, however, be the primary determining factor
because Cho et al. did not observe action potentials in v-
myc derived human NSCs [7].
Conclusion
We conclude that: 1) immunocytochemical characteriza-
tion is not sufficient to identify the functional maturation
of different cell types and 2) differences in culturing con-
ditions might enhance the property of generating func-
tional neurons, but the property itself seems to be
intrinsic to a specific cell line which may arise from the
method used to prepare the cell line. Further studies are
required to elucidate the determining factors for human
fetal derived neural stem cells to be maturated into func-
tional neurons.
Methods
Cell line derivation
The procedure to derive cell lines is similar to that recently
reported [29]. The ReNcell VM line was derived from ten-
week gestation fetal midbrain tissue that was obtained
from Kings College Hospital, London, whereas the ReN-
cell CX line was derived from a 14-week gestation fetal
cortex obtained from Advanced Bioscience Resources
(Alameda CA, USA), both following normal terminations
and in accordance with nationally (UK and/or USA)
approved ethical and legal guidelines. The tissues were
collected in ice-cold HBSS without Ca2+/Mg2+ (Gibco),
containing 1 mM N-acetyl cysteine (Sigma). The appropri-
ate brain region was isolated and cleaned under a dissec-
tion microscope. Single cells were isolated by choppingBMC Neuroscience 2007, 8:36 http://www.biomedcentral.com/1471-2202/8/36
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the tissue with a scalpel and then incubating in 0.25% w/
v trypsin (BioWhittaker) in DMEM:F12 (Gibco) contain-
ing 25 U/ml Benzonase (Merck) for 15 min at 37°C. Fol-
lowing the dissociation, twice the volume of trypsin
inhibitor solution (0.55 mg/ml soybean trypsin inhibitor,
Sigma, dissolved in DMEM:F12, containing 1% human
serum albumin (Grifols) and 25 U/ml Benzonase) was
added. Cells were centrifuged at 800 g for 5 min, then
resuspended in serum free human media comprising
DMEM:F12 supplemented with human serum albumin
(0.03%), human transferrin (100 µg/ml, Sigma),
putrescine dihydrochloride (16.2 µg/ml, Sigma), human
insulin (5 µg/ml, Sigma), L-thyroxine (T4, 400 ng/ml,
Sigma), tri-iodo-thyronine (T3, 337 ng/ml, Sigma), pro-
gesterone (60 ng/ml, Sigma), L-Glutamine (2 mM,
Gibco), sodium selenite (selenium, 40 ng/ml, Sigma),
heparin, sodium salt (10 Units/ml, Sigma), corticosterone
(40 ng/ml, Sigma) and Gentamycin (50 ug/ml, Gibco) in
the presence of bFGF (10 ng/ml, Invitrogen) and EGF(20
ng/ml, Sigma). Dissociated cells from the two different
brain regions were plated on laminin coated flasks (Invit-
rogen, coated at 20 µg/ml in DMEM:F12 for 1 hr at 37°C
followed by one wash with warm DMEM:F12) at a con-
centration of 5 × 104 cells/cm2 and maintained at 37°C in
a humidified atmosphere of 95% air/5% CO2. MMLV type
retrovirus encoding the v- or c- myc genes was generated
using the TEFLY-A (amphotropic) virus packaging cell line
as previously described [30]. Midbrain derived cells were
then infected for 8 h with fresh media containing retrovi-
rus carrying the v-myc gene in the presence of 4 µg/ml
polybrene, whereas the cortex derived cells were infected
under the same conditions except c-myc containing retro-
virus was used, both driven under the CMV promoter.
Three successive infections were carried out. Following
infection, cells were placed under antibiotic selection
(ReNcell VM 150 µg/ml geneticin and ReNcell CX 75 µg/
ml hygromycin, both supplied by Gibco). Putting the
bulk infected mid-brain culture under selection for 2–3
weeks generated the ReNcell VM line. The cortical cells
were plated at low density (~2000 cells) in a 15 cm diam-
eter tissue culture dish and put under selection for 2–3
weeks. Resistant colonies were picked using the cloning
ring method (8 mm cloning ring, Sigma). A series of
approximately 15 clonal cell lines were isolated (data not
shown). Clone 27 was designated ReNcell CX and moved
forward because of its capacity to differentiate into mor-
phologically distinct neurons. Confirmation of myc trans-
gene expression in both ReNcell VM and CX was
confirmed by RT-PCR using the following primer
sequences: (5' – 3') AGCTGGTTTAGTGAACCGTCAGATC
(F); AGCAGCTCGAATTTCTTCCA (R) (Sigma). The for-
ward primer sequence is targeted against the CMV pro-
moter shared by both transgenes and the reverse primer
against a homologous region between c-myc and v-myc
with a single band product from each of 265 bp.
Cell culture
Having established the cell lines as described, cells were
routinely expanded for experimental work on laminin
coated T75 cm2 or T175 cm2 tissue culture flasks (Nunc
Easyflask) in B27 medium [DMEM:F12 containing B27
neural cell supplement mix (Gibco), L-Glutamine (2 mM,
Gibco), heparin (10 Units/ml, Sigma) and Gentamicin
(50 µg/ml, Gibco)] in the presence of bFGF (10 ng/ml,
Invitrogen) and EGF (20 ng/ml, Sigma) – referred to as
growth medium. All cells in culture were maintained at
37°C in a humidified atmosphere of 95% air/5% CO2. It
is important not to allow the cells to become confluent (>
80% confluency) at any time. Cells were passaged every
three to four days using trypsin and trypsin inhibitor solu-
tions. Briefly, cells were rinsed with HBSS without Ca2+/
Mg2+ and then incubated in trypsin solution for 5–15 min
until the cells detached. Twice the volume of trypsin
inhibitor was added and the cells centrifuged at 500 g × 5
min. The cell pellet was resuspended in fresh medium and
plated in a freshly laminin coated flask(s) at a density of
~10000 cells/cm2. For consistency and practical reasons,
all experiments presented in this study were carried out on
cells between passages 15 and 30. However, karyotype
analyses were carried out on longer-term cultures and
found to be normal.
Cell proliferation assays
To monitor the growth rate, cells were seeded at 2,000
cells/well on laminin coated 96-well tissue culture plates
(removable strip plates, Corning). Every day two strips
were removed (n = 16), media aspirated, and plates stored
dry at -70°C. The relative number of cells was determined
using CyQuant cell proliferation assay (Molecular Probes)
according to the manufacturer's instructions. Fluorescent
measurements were made on a microplate reader (Tecan,
Genios).
Differentiation
Cells were passaged into laminin-coated 96-well plates
(BD Biosciences) for differentiation assays. Differentia-
tion of both cell lines was carried out using two different
protocols. For standard differentiation (stdD) assays, cells
were seeded at 30,000 cells/cm2 in a 96-well plate (10,000
cells/well) and expanded to confluency in growth
medium over a 3–4 day period. Differentiation was initi-
ated by changing the medium to that without growth fac-
tors. Following approximately 4–7 days' differentiation,
cells were fixed for immunocytochemistry. The pre-aggre-
gation differentiation (preD) protocol was observed to
enrich the dopaminergic phenotype differentiation of the
ReNcell VM line. Aggregates were made by seeding 30,000
cells/cm2 (10,000 cells/well) on uncoated 96-well plates
in growth medium and left expanding for 7 days with no
media change. At this point, the aggregates were harvested
and dissociated by gentle trituration and replated on lam-BMC Neuroscience 2007, 8:36 http://www.biomedcentral.com/1471-2202/8/36
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inin-coated 96-well plates with the dissociated cells from
one aggregate preparation placed in an equivalent sized
well (plating density of 1:1 based on surface area). The
cells were then differentiated using the stdD assay as
described above. Where described, 1 mM dibutyrl-cAMP
(Calbiochem) and 2 ng/ml GDNF (Peprotech) was added
to the differentiation media. In some cases plating was
sparser with an aggregate preparation being divided
between two or more wells (plating density of 1:2; 1:3
etc).
Immunocytochemistry
Following growth and/or differentiation on laminin-
coated 96-well culture plates, the medium was removed
and the cells fixed for 15 minutes in cold 4% paraformal-
dehyde/PBS followed by two PBS washes. Cells were per-
meabilised with 0.1% Triton × 100 in PBS for 15 minutes
and non- specific binding was blocked with 10% normal
goat serum (NGS, Vector labs) in PBS for 1 hour at room
temperature. Nestin was probed using mouse monoclonal
anti-nestin at 1:600 (Chemicon, MAB5326), βIII-tubulin
was probed using a mouse monoclonal at 1:1000 (Sigma,
UK), anti-GFAP rabbit polyclonal at 1:5000 (DAKO), and
anti-tyrosine hydroxylase (TH) used at 1:250 (Chemicon,
AB152). Primary antibodies were incubated overnight at
room temperature. After washing twice with PBS, they
were then processed with filtered Alexa dye conjugated
Goat anti-Mouse 488 (1:250; Molecular Probes) or Alexa
dye conjugated Goat anti-Rabbit 568 (1:2500; Molecular
Probes) dissolved in 1% NGS in PBS for 1.5 hour at room
temperature. Cells were washed with PBS and counter-
stained with 10 mM Hoechst 33342 (Sigma) for 4 min-
utes followed by an additional PBS wash.
Western blot
Protein expression in cell samples from 96-well plates
were analyzed by western blotting. Cells were gently
washed twice for 5 minutes each time with 200 µl PBS and
subsequently lysed with 50–150 µl 1X SDS-Sample buffer
(15 mM Tris pH 6.8, 5% glycerol, 1% β-mercaptoethanol,
1% SDS, 0.002% bromophenol blue). The cell lysate was
then heated for 5 min at 70°C prior to resolution on a 10
well × 1 mm thick SDS-PAGE (Novex) and blotted to
nitrocellulose membrane (Whatman Schleicher & Schuell
BioScience, BA85) using a Mini-VE blotting apparatus
(Invitrogen) as per manufacturers' guidelines. Non-spe-
cific binding of the blotted membrane was blocked with
5% non-fat dried milk diluted in wash buffer (0.1% tween
20/PBS) for 1 h. The membrane was then probed with
anti-nestin (ATCC, 2 µg/ml), tyrosine hydroxylase
(Chemicon, AB152, 1:250), βIII-tubulin (Sigma, 1:500)
or α-tubulin (Sigma, 1:1000) diluted in wash buffer for 1
hr. After three washes, the membranes were incubated in
peroxidase-linked secondary antibodies (anti-mouse HRP
or anti-rabbit HRP, Amersham, 1:5000) for 1 hour then
washed and developed with Supersignal West Femto
detection kit (Pierce). Images were captured using a Bio-
Rad Fluor-S digital imaging system.
Electrophysiology
For electrophysiology studies, cells were plated on 13 mm
diameter laminin coated Thermanox (Nalge Nunc Inter-
national) coverslips in the growth medium. Control cells
were grown in growth media and measured following 3–
4 days' growth. In general protocols for stdD and preD are
followed as described above. In the case of ReNcell VM
samples prepared for electrophysiology using the preD
protocol, the seeding density is expressed as the ratio of
dilution of the aggregates following 7 days expansion
from an initial seeding density of 30000 cells/cm2. At
specified times (days of differentiation), coverslips were
placed in a recording chamber on the stage of an upright
microscope (Olympus). Cells were perfused with an extra-
cellular solution containing (in mM): 125 NaCl, 2.4 KCl,
2 CaCl2, 1 MgCl2, 26 NaHCO3, 1.1 NaH2PO4, 10 glucose,
and bubbled with 95% O2 /5% CO2. The conventional
whole cell patch clamp technique [31] was employed by
using an an Axopatch 1-D patch-clamp amplifier, (Axon
Instruments, Foster City, CA) both for current clamp and
voltage clamp recordings. Electrodes were pulled from
thick walled borosilicate glass (World Precision Instru-
ments, Hertfordshire, UK) to a tip resistance of 4–6 MΩ
(PP-83 microelectrode puller; Narishige, Tokyo, Japan)
when filled with an intracellular solution containing (in
mM): 130 KGluconate, 10 NaCl, 10 HEPES, 10 EGTA, 2
MgATP, and 1 MgCl2, pH 7.4 with NaOH and osmolality
298 mOsm with 25 glucose. Voltage and current pulse
generation and data acquisition were performed with a PC
running the WCP software (University of Strathclyde,
Scotland). Data were sampled at 10 kHz with an A/D
interface (Digidata 1200). Membrane potentials were cor-
rected off line for the liquid junction potential, which was
measured as -15 mV. Cell input resistance (Rin) was esti-
mated from the current response to small (5 mV) hyper-
polarizing voltage command from the holding potential
(-60 mV). The protocols for measuring Na+ currents and
action potentials are detailed in the figure legends. The
voltage clamp protocol for testing active potassium IA con-
ductance consisted of a 400 ms hyperpolarizing pulse
from a holding potential of -60 to -120 mV to remove
inactivation, followed by 400 ms depolarizing steps in 10
mV increments at 0.5 Hz. This protocol was then followed
by a similar one but with the prepulse at +30 mV in order
to inactivate the IA conductance. Digitally subtracting the
responses from these two protocols results in an estimate
of the pure IAcurrent.
Abbreviations
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hNSCs human neural stem cells
VM ventral mesencephalon
CX cortex
stdD standard differentiation protocol
preD preaggregate differentiation protocol
TH tyrosine hydroxylase
TTX tetrodotoxin
GFs growth factors bFGF and EGF
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